Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Thompson

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
The Oncologist|April 5, 2019
Exploring Patient Decision Making Regarding Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid LeukemiaKathryn E Flynn, Judith M Myers, Anita D'Souza, et al.
Blood Reviews|January 24, 2015
Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapyLin Mei, Evelena P Ontiveros, Elizabeth A Griffiths, et al.
Leukemia Research Reports|September 3, 2014
High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failureMorgan B Smith, Elizabeth A Griffiths, James E Thompson, et al.
Leukemia & Lymphoma|December 19, 2017
Combining blinatumomab with targeted therapy for BCR-ABL mutant relapsed/refractory acute lymphoblastic leukemiaAhmad Hanif, Eunice S Wang, James E Thompson, et al.
Experimental Hematology|July 22, 2010
Interferon regulatory factor-8-driven myeloid differentiation is regulated by 12/15-lipoxygenase-mediated redox signalingMichelle Kinder, James E Thompson, Cong Wei, et al.
The Journal of Biological Chemistry|June 4, 2010
The K5 lyase KflA combines a viral tail spike structure with a bacterial polysaccharide lyase mechanismJames E Thompson, Meraj Pourhossein, Amy Waterhouse, et al.
European Urology|November 30, 2013
Superior quality of life and improved surgical margins are achievable with robotic radical prostatectomy after a long learning curve: a prospective single-surgeon study of 1552 consecutive casesJames E Thompson, Sam Egger, Maret Böhm, et al.
Bioorganic Chemistry|July 30, 2011
Limits to Catalysis by Ribonuclease AJames E Thompson, Tatiana G Kutateladze, Michael C Schuster, et al.
The Journal of Biological Chemistry|March 30, 2004
A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyaseKevin J Murphy, Catherine L R Merry, Malcolm Lyon, et al.
The Oncologist|December 25, 2019
In ReplyKathryn E Flynn, David J Vanness, Judith M Myers, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
The Oncologist|April 5, 2019
Exploring Patient Decision Making Regarding Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid LeukemiaKathryn E Flynn, Judith M Myers, Anita D'Souza, et al.
Blood Reviews|January 24, 2015
Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapyLin Mei, Evelena P Ontiveros, Elizabeth A Griffiths, et al.
Leukemia Research Reports|September 3, 2014
High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failureMorgan B Smith, Elizabeth A Griffiths, James E Thompson, et al.
Leukemia & Lymphoma|December 19, 2017
Combining blinatumomab with targeted therapy for BCR-ABL mutant relapsed/refractory acute lymphoblastic leukemiaAhmad Hanif, Eunice S Wang, James E Thompson, et al.
Experimental Hematology|July 22, 2010
Interferon regulatory factor-8-driven myeloid differentiation is regulated by 12/15-lipoxygenase-mediated redox signalingMichelle Kinder, James E Thompson, Cong Wei, et al.
The Journal of Biological Chemistry|June 4, 2010
The K5 lyase KflA combines a viral tail spike structure with a bacterial polysaccharide lyase mechanismJames E Thompson, Meraj Pourhossein, Amy Waterhouse, et al.
European Urology|November 30, 2013
Superior quality of life and improved surgical margins are achievable with robotic radical prostatectomy after a long learning curve: a prospective single-surgeon study of 1552 consecutive casesJames E Thompson, Sam Egger, Maret Böhm, et al.
Bioorganic Chemistry|July 30, 2011
Limits to Catalysis by Ribonuclease AJames E Thompson, Tatiana G Kutateladze, Michael C Schuster, et al.
The Journal of Biological Chemistry|March 30, 2004
A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyaseKevin J Murphy, Catherine L R Merry, Malcolm Lyon, et al.
The Oncologist|December 25, 2019
In ReplyKathryn E Flynn, David J Vanness, Judith M Myers, et al.
Pageof 10